Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections
出版年份 2022 全文链接
标题
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections
作者
关键词
-
出版物
BRAIN BEHAVIOR AND IMMUNITY
Volume 103, Issue -, Pages 154-162
出版商
Elsevier BV
发表日期
2022-04-18
DOI
10.1016/j.bbi.2022.04.013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US
- (2021) Carl A. Latkin et al. PLoS One
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- High-dimensional characterization of post-acute sequelae of COVID-19
- (2021) Ziyad Al-Aly et al. NATURE
- Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
- (2021) Alberto Mateo-Urdiales et al. Eurosurveillance
- Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
- (2021) Adeel A. Butt et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
- (2021) Catherine Hyams et al. LANCET INFECTIOUS DISEASES
- Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
- (2021) Michela Antonelli et al. LANCET INFECTIOUS DISEASES
- Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
- (2021) Maxime Taquet et al. PLOS MEDICINE
- COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
- (2021) Utkarsh Agrawal et al. Lancet Respiratory Medicine
- The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
- (2021) Aharona Glatman-Freedman et al. EBioMedicine
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
- (2020) Simon de Lusignan et al. LANCET INFECTIOUS DISEASES
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Criteria for use of composite end points for competing risks—a systematic survey of the literature with recommendations
- (2017) Veena Manja et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Using Electronic Health Records for Population Health Research: A Review of Methods and Applications
- (2016) Joan A. Casey et al. Annual Review of Public Health
- The Propensity Score
- (2015) Jason S. Haukoos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now